Psychiatric Times November 21, 2025
Key Takeaways
- Prescription Digital Therapeutics (PDTs) are FDA-cleared, supported by clinical trials, and require healthcare provider prescriptions.
- PDTs offer scalable, nonpharmacologic treatment options, benefiting underserved populations and providing real-time adherence tracking.
- Challenges include reimbursement inequity, digital literacy issues, privacy concerns, and access inequities, particularly in underserved populations.
- PDTs demonstrate significant improvements in patient outcomes, such as ADHD symptom reduction and parental satisfaction with EndeavorRx.
Digital therapeutics revolutionize health care by enhancing patient outcomes through technology and offering scalable, evidence-based treatments for various conditions.
CONFERENCE REPORTER
“The digital revolution is transforming all of our lives, including health care delivery,” said Gus Alva, MD, at the 2025 Southern Florida Psychiatry Conference in West Palm Beach, Florida.
In the very first...
Today's Sponsors
Today's Sponsor